Nanolive hosts this event on “Non-invasive, high content live cell assays to increase translational relevance of in vitro drug development of biologics and small molecules”. In this webinar, we present the following use-cases of our immuno-oncology and...
Congratulations to the Conrad lab for their latest Nature paper ‘Phase separation of FSP1 promotes ferroptosis’! This beautiful capture published as part of the paper provides new information about the events leading up to ferroptotic cell death. Using...
We are thrilled to announce a groundbreaking scientific study authored by Mathieu Frechin and Daniel Olive, in collaboration with Aix Marseille Université, ImCheck therapeutics, and Nanolive. Their remarkable research on Vγ9Vδ2 T cells has opened up new possibilities...
On June 20th, Nanolive has launched another ground-breaking tool in cell analysis: the LIVE Cytotoxicity Assay, an AI-powered digital assay with fluorescent labelling that monitors the responses of different cell lines in co-culture simultaneously. For this event, we...
We are happy to see that Nanolive imaging has been used to confirm the success of another new therapy, this time treating melasma. In their latest paper “Depigmenting topical therapy based on a synergistic combination of compounds targeting the key pathways involved...